Why This Matters for Your Career
Hetero is hiring 5 roles related to this product
Company
Hetero
India - Hyderabad
SOLRIAMFETOL (solriamfetol) by Hetero is dopamine uptake inhibitors [moa].
Drug data last refreshed 8h ago
Dopamine Uptake Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
Worked on SOLRIAMFETOL at Hetero? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Hetero is hiring 5 roles related to this product